Skip to main content

Published locations for FDA advisors recommend nintedanib for SSc interstitial lung disease

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA advisors recommend nintedanib for SSc interstitial lung disease

User login

  • Reset your password
  • /content/fda-advisors-recommend-nintedanib-ssc-interstitial-lung-disease
  • /fedprac/article/205354/lupus-connective-tissue-diseases/fda-advisors-recommend-nintedanib-ssc
  • /internalmedicinenews/article/205354/lupus-connective-tissue-diseases/fda-advisors-recommend
  • /rheumatologynews/article/205354/lupus-connective-tissue-diseases/fda-advisors-recommend-nintedanib
  • /pulmonary-health-hub/article/205354/lupus-connective-tissue-diseases/fda-advisors-recommend
  • /rheumatology/article/205354/lupus-connective-tissue-diseases/fda-advisors-recommend-nintedanib-ssc
  • /internalmedicine/article/205354/lupus-connective-tissue-diseases/fda-advisors-recommend-nintedanib
  • /chestphysician/article/205354/lupus-connective-tissue-diseases/fda-advisors-recommend-nintedanib-ssc